Mario Alberto Accardi

Insider Reports History

Location
Cheshire
Signature
/s/ Raphael Deferiere, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mario Alberto Accardi:

Company Role Class Num Shares Value Price $ Report Date Ownership
Centessa Pharmaceuticals plc Chief Executive Officer, Director Ordinary Shares 243,886 $6,099,588 $25.01 02 Feb 2026 Direct
Centessa Pharmaceuticals plc Chief Executive Officer, Director Share Option (right to buy) 273,000 02 Feb 2026 Direct

Insider Reports Filed by Mario Alberto Accardi

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CNTA Centessa Pharmaceuticals plc 01 Feb 2026 3 -$71,622 4 Chief Executive Officer, Director 03 Feb 2026, 18:55
CNTA Centessa Pharmaceuticals plc 09 Dec 2025 2 -$288,289 4 President, Orexin Program 09 Dec 2025, 19:07
CNTA Centessa Pharmaceuticals plc 08 Dec 2025 3 -$252,350 4 President, Orexin Program 08 Dec 2025, 18:26
CNTA Centessa Pharmaceuticals plc 01 Nov 2025 1 -$14,766 4 President, Orexin Program 03 Nov 2025, 16:14
CNTA Centessa Pharmaceuticals plc 27 Oct 2025 3 -$159,950 4 President, Orexin Program 27 Oct 2025, 19:56
CNTA Centessa Pharmaceuticals plc 16 Sep 2025 2 -$174,846 4 President, Orexin Program 16 Sep 2025, 18:16
CNTA Centessa Pharmaceuticals plc 09 Sep 2025 3 -$99,950 4 President, Orexin Program 11 Sep 2025, 17:45
CNTA Centessa Pharmaceuticals plc 01 Aug 2025 1 -$10,250 4 President, Orexin Program 01 Aug 2025, 17:00
CNTA Centessa Pharmaceuticals plc 29 Jul 2025 1 -$126,751 4 President, Orexin Program 30 Jul 2025, 17:00
CNTA Centessa Pharmaceuticals plc 24 Jun 2025 3 -$152,250 4 President, Orexin Program 25 Jun 2025, 19:42
CNTA Centessa Pharmaceuticals plc 13 Jun 2025 0 $0 3 President, Orexin Program 24 Jun 2025, 16:08